Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
PTC
PTC
$14.7B
| $6.01M | ﹤0.01% |
50,198
-59,030
| -54% | -$7.87M |
|
|
GOGL
1677
DELISTED
Golden Ocean Group
GOGL
| $5.99M | ﹤0.01% |
566,953
+245,994
| +77% | +$2.56M |
|
1678
ProShares S&P Technology Dividend Aristocrats ETF
TDV
$268M
| $5.98M | ﹤0.01% |
100,000
| – | – |
|
1679
H&R Block
HRB
$5.7B
| $5.96M | ﹤0.01% |
238,441
-60,956
| -20% | -$1.52M |
|
1680
Thor Industries
THO
$4.13B
| $5.96M | ﹤0.01% |
48,529
+33,870
| +231% | +$3.87M |
|
1681
CALL
CSX Corp
CSX
$94.2B
| $5.95M | ﹤0.01% |
+200,000
| New | +$6.4M |
|
1682
InMode
INMD
$889M
| $5.95M | ﹤0.01% |
74,560
-55,846
| -43% | -$3.41M |
|
1683
Old Republic International
ORI
$10.8B
| $5.94M | ﹤0.01% |
256,738
-3,945
| -2% | -$97.6K |
|
1684
Celldex Therapeutics
CLDX
$2.79B
| $5.9M | ﹤0.01% |
109,309
-10,945
| -9% | -$514K |
|
|
ADAM
1685
Adamas Trust
ADAM
$783M
| $5.9M | ﹤0.01% |
346,045
+124,879
| +56% | +$2.17M |
|
1686
PUT
APA Corp
APA
$12.3B
| $5.89M | ﹤0.01% |
275,000
| – | – |
|
|
HZNP
1687
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $5.89M | ﹤0.01% |
+53,800
| New | +$5.59M |
|
1688
SPS Commerce
SPSC
$2.51B
| $5.89M | ﹤0.01% |
36,530
-9,938
| -21% | -$1.22M |
|
1689
Itaú Unibanco
ITUB
$91.6B
| $5.88M | ﹤0.01% |
1,533,840
-5,936,507
| -79% | -$24.3M |
|
1690
SiriusXM
SIRI
$10.7B
| $5.86M | ﹤0.01% |
96,143
-22,657
| -19% | -$1.42M |
|
1691
Sun Life Financial
SLF
$46.6B
| $5.86M | ﹤0.01% |
113,767
-22,328
| -16% | -$1.15M |
|
1692
Morningstar
MORN
$7.38B
| $5.85M | ﹤0.01% |
22,602
-3,015
| -12% | -$792K |
|
1693
PUT
American Tower
AMT
$79.9B
| $5.84M | ﹤0.01% |
22,000
+4,000
| +22% | +$1.14M |
|
|
BERY
1694
DELISTED
Berry Global Group, Inc.
BERY
| $5.84M | ﹤0.01% |
104,424
-197,226
| -65% | -$11.7M |
|
|
DAY
1695
DELISTED
Dayforce
DAY
| $5.83M | ﹤0.01% |
51,796
-178,485
| -78% | -$18.7M |
|
|
SEE
1696
DELISTED
Sealed Air
SEE
| $5.83M | ﹤0.01% |
106,379
-47,415
| -31% | -$2.75M |
|
|
KC
1697
Kingsoft Cloud Holdings
KC
$3.03B
| $5.82M | ﹤0.01% |
205,361
+16,274
| +9% | +$483K |
|
|
API
1698
PUT
Agora
API
$333M
| $5.8M | ﹤0.01% |
200,000
| – | – |
|
1699
ACV Auctions
ACVA
$1.43B
| $5.8M | ﹤0.01% |
324,008
+15,815
| +5% | +$336K |
|
|
CERE
1700
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $5.8M | ﹤0.01% |
196,493
+131,492
| +202% | +$3.69M |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.